checkAd

    Pironet - Outperformer (Merck Finck & Co) 16.02.2001 - 500 Beiträge pro Seite

    eröffnet am 16.02.01 13:48:20 von
    neuester Beitrag 17.02.01 01:34:50 von
    Beiträge: 2
    ID: 343.769
    Aufrufe heute: 0
    Gesamt: 268
    Aktive User: 0

    ISIN: DE0006916406 · WKN: 691640
    4,4000
     
    EUR
    +4,74 %
    +0,1990 EUR
    Letzter Kurs 24.03.15 Xetra

    Werte aus der Branche Informationstechnologie

    WertpapierKursPerf. %
    1,4900+47,51
    0,6120+32,75
    3,0400+25,62
    1,5000+20,00
    35,12+19,99
    WertpapierKursPerf. %
    2,7300-14,69
    1,1000-15,38
    4,0700-19,41
    0,7500-40,00
    1,0100-54,09

     Durchsuchen

    Begriffe und/oder Benutzer

     

    Top-Postings

     Ja Nein
      Avatar
      schrieb am 16.02.01 13:48:20
      Beitrag Nr. 1 ()
      Pironet - Outperformer (Merck Finck & Co)
      Pironet announced ist annual 2000 sales and EBIT figures. The company managed to increase sales on a year to year bases by 111% accounting for €24.75m. We estimated sales of €24.8m indicating a satisfactory sales result in line with our sales projections. The EBIT loss €-2.2m is furthermore meet our estimates. A one pager with further information is soon to come.



      (Quelle: Merck Finck & Co)
      Avatar
      schrieb am 17.02.01 01:34:50
      Beitrag Nr. 2 ()
      Pironet - Outperformer (Merck Finck & Co)
      Pironet announced its annual sales and EBIT figures today. The company managed to achieve an 111% sales growth organically excluding the acquisition of NDH, a leading German ASP. Total sales amounted for €24.75m almost exactly fulfilling our previous estimate of €24.8m. Software license sales did show an even more dynamic development with an 156% increase adding up to €3.5m. Pironet`s own sales projections for 2001 account for €35m indicating an 45% sales increase.

      EBIT accounted for €-2.25m showing an upward swing of 33% in comparison to the previous year EBIT of €-3.37m. The EBIT loss was exactly in line with our optimistic prospects justifying our positive outlook. The favourable development is mainly driven by the increased high margin license sales.

      The external acquisition-driven growth potential for Pironet is substantial if we bear in mind that the company has €35m in cash. Due to the expected positive net income and cash flow development in 2001 the funds will be made available for potential take-over activities. Especially after the sharp decease in valuation of several companies within the broader content management segment, the high liquidity level should provide ample buying opportunities.

      The improved market standing of Pironet is also validated by the latest co- operation with the leading Scandinavian multi-media agency, Framfab. The co-operation represents an additional implementation partner for the standard software Pirobase to add breadth to the distribution channels. Cap Gemini Ernest & Young was also gained as a co-operation partner providing Pirobase with access to the global network of one of the most prestigious and largest consulting companies in the world. Both co-operations should boost sales and net income figures.

      Apart from EBIT and sales figures, no other financials were published today. More detailed information will be given in 20 th in a conference call on February 20th.

      We maintain our EPS estimates and outperformer recommendation due to strong fundamentals and the low valuation of Pironet shares.



      (Quelle: Merck Finck & Co)




      16.02.2001 14:29
      ©boerse.de


      Beitrag zu dieser Diskussion schreiben


      Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
      Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie
      hier
      eine neue Diskussion.

      Investoren beobachten auch:

      WertpapierPerf. %
      +0,07
      -0,60
      -0,23
      -0,90
      +1,58
      -0,45
      -0,52
      -0,74
      +3,38
      -0,88

      Meistdiskutiert

      WertpapierBeiträge
      200
      184
      132
      70
      29
      29
      29
      26
      26
      26
      Pironet - Outperformer (Merck Finck & Co) 16.02.2001